InvestorsHub Logo
Followers 3
Posts 292
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Wednesday, 04/05/2023 9:00:40 AM

Wednesday, April 05, 2023 9:00:40 AM

Post# of 3283
New corporate presentation posted. Interesting slides:
#3. New person in management team, Erin Miller, Senior Vice President Sales and Marketing. She worked at Amgen.
#6. Shows a difference in molecular structures of Rolvedon and Neulasta. I like it.
#7. Familiar bar graphs demonstrating effects of Rolvedon and Neulasta on incidence and duration of severe neutropenia. All in favor of Rolvedon but no error bars and p values.
#11. Rolvedon launch plan including all incremental steps and time. Who made this slide is a creative person.
Not a word about Poziotinib.
https://investor.sppirx.com/static-files/2977ecaa-f5d9-42e3-91af-ed6738a39993